Fariborz Kamal
President and Chief Operating Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-12-31
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Operating Officer & President | $546,273 | $734,607 |
| 2023 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Operating Officer & President | $489,389 | $4,544,260 |
| 2022 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Operating Officer & President | $468,983 | $2,386,301 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.